Popular Trials
Eluxadoline for Irritable Bowel Syndrome
Recruiting0 awardsPhase 2
Hot Springs, Arkansas
This trial is testing a medication to help manage IBS-D symptoms in children. The goal is to see how well it works, how the body processes it, and if it is safe for kids. The study focuses on children because they need effective treatments for IBS-D. The medication is taken orally and is designed to treat diarrhoea-predominant irritable bowel syndrome.
Behavioral Intervention
Positive Psychology for Irritable Bowel Syndrome
Recruiting1 award
Boston, Massachusetts
This trial aims to see if a new positive psychology intervention called "WISH" is helpful for patients with irritable bowel syndrome. Researchers will compare this new intervention to a control group that receives educational information
Popular Filters
Trials for IBS Patients
Microbiota Restoration
Fecal Microbiota Transplant for Irritable Bowel Syndrome
Recruiting0 awardsPhase 2
Rochester, Minnesota
This trial studies the safety and effectiveness of FMT using donor stool with low protein breakdown and Alistipes putredinis bacteria to treat PI-IBS and high protein breakdown.
Behavioral Intervention
Social Learning and Cognitive Behavioral Therapy for Irritable Bowel Syndrome
Recruiting0 awards
Seattle, Washington
This trial tests if using specific websites can help parents with IBS teach their young children healthy habits. The goal is to reduce the risk of children developing stomach pain by improving how parents manage stress and support their kids. The study involves parents using one of two websites focused on child health or wellness.
Behavioral Intervention
GUT LINK SmartPath for Irritable Bowel Syndrome
Recruiting1 award
Halifax, Nova Scotia
This trial aims to test a new set of guidelines to help doctors better diagnose and treat patients with digestive issues like IBS. The goal is to make it easier for primary care doctors to manage these conditions without needing specialists or invasive tests.
Behavioural Intervention
Mindfulness Training for Irritable Bowel Syndrome
Recruiting1 award
Pittsburgh, Pennsylvania
This trial will compare the effectiveness of two different mindfulness-based interventions (MBIs) for treating irritable bowel syndrome (IBS), with a control group who will receive stress management training. The trial will use both clinician and patient assessed measures of IBS symptoms, as well asEcological Momentary Assessment to assess stress and symptoms in daily life.
Mu-opioid Receptor Agonist
Eluxadoline for Pediatric IBS-D
Recruiting2 awardsPhase 3
Oklahoma City, Oklahoma
This trial will check the safety of a medication called Eluxadoline for children with IBS-D who have already taken part in earlier studies. The medication helps to reduce diarrhea and stomach pain by slowing down bowel movements. Eluxadoline is a new drug approved for managing diarrhea predominant irritable bowel syndrome (IBS-D).
Trials With No Placebo
Behavioral Intervention
GUT LINK SmartPath for Irritable Bowel Syndrome
Recruiting1 award
Halifax, Nova Scotia
This trial aims to test a new set of guidelines to help doctors better diagnose and treat patients with digestive issues like IBS. The goal is to make it easier for primary care doctors to manage these conditions without needing specialists or invasive tests.
Behavioural Intervention
Mindfulness Training for Irritable Bowel Syndrome
Recruiting1 award
Pittsburgh, Pennsylvania
This trial will compare the effectiveness of two different mindfulness-based interventions (MBIs) for treating irritable bowel syndrome (IBS), with a control group who will receive stress management training. The trial will use both clinician and patient assessed measures of IBS symptoms, as well asEcological Momentary Assessment to assess stress and symptoms in daily life.
Mu-opioid Receptor Agonist
Eluxadoline for Pediatric IBS-D
Recruiting2 awardsPhase 3
Oklahoma City, Oklahoma
This trial will check the safety of a medication called Eluxadoline for children with IBS-D who have already taken part in earlier studies. The medication helps to reduce diarrhea and stomach pain by slowing down bowel movements. Eluxadoline is a new drug approved for managing diarrhea predominant irritable bowel syndrome (IBS-D).
Non-invasive Brain Stimulation
Brain Stimulation for Gastrointestinal Disorders
Recruiting1 award3 criteria
Pittsburgh, Pennsylvania
This trial is testing a non-invasive brain stimulation technique called rTMS on healthy people and those with IBS or FD. The goal is to see if it can help regulate automatic body functions like digestion and heart rate by changing brain activity. Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive brain stimulation technique that has been used to treat various neurological and psychiatric conditions, including major depression, migraine-associated headaches, and obsessive-compulsive disorder.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.